Comparison Chart ORIC Pharmaceuticals, Inc. Börse Stuttgart

Stocks

4TZ

US68622P1093

Biotechnology & Medical Research

Real-time Estimate Tradegate 11:30:09 16/10/2026 +04			5-day change	1st Jan Change
11.35 ^EUR	-0.19%		+6.41%	+64.78%

09-15	ORIC Pharmaceuticals, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 10:00 AM
08-29	Oric Pharmaceuticals Insider Sold Shares Worth $1,053,814, According to a Recent SEC Filing	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	ORIC PHARMACEUTICALS, INC.	Bio Therapeutic Drugs	-1.85%	+6.41%	-	-	-	1.32B	-	-	-